PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19725099-8	2009	EBC MMP-9 levels were inversely correlated with pulmonary functions test, and positively with HRCT scores and annual number of pulmonary infections.In conclusion, this study showed that EBC of children with both CF BE and non-CF BE contained higher levels of MMP-9 in comparison to controls.	NSC638702	0-3	matrix metallopeptidase 9	Homo sapiens	4-9	
30057384-1	2018	Introduction Data on the measurement of matrix metalloproteinase 9 (MMP-9) in exhaled breath condensate (EBC) from patients with chronic obstructive pulmonary disease (COPD) are scarce and inconsistent.	NSC638702	105-108	matrix metallopeptidase 9	Homo sapiens	40-66	
30057384-1	2018	Introduction Data on the measurement of matrix metalloproteinase 9 (MMP-9) in exhaled breath condensate (EBC) from patients with chronic obstructive pulmonary disease (COPD) are scarce and inconsistent.	NSC638702	105-108	matrix metallopeptidase 9	Homo sapiens	68-73	
30057384-2	2018	Objectives We aimed to assess the usefulness of enzyme-linked immunosorbent assay (ELISA) and immunoenzymatic assay (IEA) for the measurement of MMP-9 in EBC, the agreement between the results of both methods, and the relationships between total and active MMP-9 in EBC and clinical and functional COPD characteristics.	NSC638702	154-157	matrix metallopeptidase 9	Homo sapiens	145-150	
30057384-8	2018	Conclusions The utility of ELISA in MMP-9 assessment in EBC is limited in COPD patients, while MMP-9 measurement in EBC by IEA is feasible.	NSC638702	56-59	matrix metallopeptidase 9	Homo sapiens	36-41	
30057384-8	2018	Conclusions The utility of ELISA in MMP-9 assessment in EBC is limited in COPD patients, while MMP-9 measurement in EBC by IEA is feasible.	NSC638702	116-119	matrix metallopeptidase 9	Homo sapiens	95-100	
27536209-3	2016	Therefore, the aim of this proof of concept study was to analyze the influence of increased doses of ICS on MMP-9 in exhaled breath condensates (EBC) of patients with allergic asthma exacerbation.	NSC638702	145-148	matrix metallopeptidase 9	Homo sapiens	108-113	
27536209-8	2016	The biochemical assessment of EBC concerned MMP-9, IL-8 and TNF.	NSC638702	30-33	matrix metallopeptidase 9	Homo sapiens	44-49	
25650123-2	2015	High levels of MMP-9 were found in mucosal biopsies, sputum and in exhaled breath condensates (EBC) of asthma patients.	NSC638702	95-98	matrix metallopeptidase 9	Homo sapiens	15-20	
24070522-4	2014	OBJECTIVE: The aim of the present study was to explore airway remodeling in different biological phenotypes of asthma by measuring MMP-9 in EBC and correlating these with other variables.	NSC638702	140-143	matrix metallopeptidase 9	Homo sapiens	131-136	
22541398-2	2012	OBJECTIVE: To evaluate MMP-9 and its natural tissue inhibitors of metalloproteinases (TIMP-1) levels of exhaled breath condensate (EBC) in children with asthma.	NSC638702	131-134	matrix metallopeptidase 9	Homo sapiens	23-28	
22541398-6	2012	RESULTS: The MMP-9 levels of EBC were found to be 57.7 +- 17.5, 35.4 +- 11.7, and 30.6 +- 3.7 ng/mL in children belonging to group 1, group 2 and group 3, respectively.	NSC638702	29-32	matrix metallopeptidase 9	Homo sapiens	13-18	
22541398-7	2012	Children belonging to group 1 and group 2 showed significantly higher MMP-9 levels of EBC in comparison with the controls (P < .001 and P = .047, respectively).	NSC638702	86-89	matrix metallopeptidase 9	Homo sapiens	70-75	
22541398-10	2012	Positive correlations were also seen between MMP-9 levels and IL-4/10 levels of EBC (r = 0.419, P = .027 and r = 0.405, P = .032, respectively) in children with asthma.	NSC638702	80-83	matrix metallopeptidase 9	Homo sapiens	45-50	
22541398-11	2012	CONCLUSION: We showed that MMP-9 levels of EBC are elevated in children with asthma and correlated with lung functions and other inflammatory markers such as IL-4/IL10 in EBC.	NSC638702	43-46	matrix metallopeptidase 9	Homo sapiens	27-32	
22832426-9	2012	Similar negative correlations were noted with FVC (% predicted), except for MMP-9 in EBC at exacerbation.	NSC638702	85-88	matrix metallopeptidase 9	Homo sapiens	76-81	
33348057-9	2021	After CPAP treatment, the EBC levels of resolvin and MMP-9 in patients with OSA returned to normal.	NSC638702	26-29	matrix metallopeptidase 9	Homo sapiens	53-58	
33348057-10	2021	CONCLUSIONS: Successful OSA treatment by CPAP can normalize EBC levels of resolvin and MMP-9.	NSC638702	60-63	matrix metallopeptidase 9	Homo sapiens	87-92	
31046512-7	2019	MMP-9 (r=-0.78, p<.0001) and TIMP-1 (r=-0.71, p<.0001) levels in EBC were significantly negatively correlated with pulmonary function FEV1%pred.	NSC638702	65-68	matrix metallopeptidase 9	Homo sapiens	0-5	
22877564-3	2012	OBJECTIVE: The aim of this study was to investigate, for the first time, MMP-9 in the exhaled breath condensate (EBC) of NSCLC patients.	NSC638702	113-116	matrix metallopeptidase 9	Homo sapiens	73-78	
22877564-6	2012	RESULTS: MMP-9 levels were found to be significantly higher in EBC, WB, and PE of NSCLC patients compared with controls.	NSC638702	63-66	matrix metallopeptidase 9	Homo sapiens	9-14	
22877564-7	2012	A positive correlation was observed between MMP-9 in EBC, cigarettes smoked, and stage of cancer.	NSC638702	53-56	matrix metallopeptidase 9	Homo sapiens	44-49	
19725099-8	2009	EBC MMP-9 levels were inversely correlated with pulmonary functions test, and positively with HRCT scores and annual number of pulmonary infections.In conclusion, this study showed that EBC of children with both CF BE and non-CF BE contained higher levels of MMP-9 in comparison to controls.	NSC638702	0-3	matrix metallopeptidase 9	Homo sapiens	259-264